rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2009-9-1
|
pubmed:abstractText |
Endoscopic variceal ligation (EVL) and propranolol are standard secondary prophylaxis therapies for variceal bleeding. Addition of isosorbide mononitrate (ISMN) to propranolol improves its hemodynamic efficacy; we investigated whether a combination of EVL and propranolol/ISMN was more effective than EVL alone for secondary prophylaxis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1528-0012
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
137
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
892-901, 901.e1
|
pubmed:meshHeading |
pubmed-meshheading:19481079-Adult,
pubmed-meshheading:19481079-Combined Modality Therapy,
pubmed-meshheading:19481079-Endoscopy, Digestive System,
pubmed-meshheading:19481079-Esophageal and Gastric Varices,
pubmed-meshheading:19481079-Female,
pubmed-meshheading:19481079-Gastrointestinal Hemorrhage,
pubmed-meshheading:19481079-Humans,
pubmed-meshheading:19481079-Hypertension, Portal,
pubmed-meshheading:19481079-Isosorbide Dinitrate,
pubmed-meshheading:19481079-Ligation,
pubmed-meshheading:19481079-Liver Circulation,
pubmed-meshheading:19481079-Male,
pubmed-meshheading:19481079-Propranolol,
pubmed-meshheading:19481079-Recurrence,
pubmed-meshheading:19481079-Risk Factors,
pubmed-meshheading:19481079-Vasodilator Agents,
pubmed-meshheading:19481079-Venous Pressure
|
pubmed:year |
2009
|
pubmed:articleTitle |
Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence.
|
pubmed:affiliation |
Department of Medical Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|